The Integration of Positron Emission Tomography With Magnetic Resonance Imaging [PDF]
, 2008 A number of laboratories and companies are currently exploring the development of integrated imaging systems for magnetic resonance imaging (MRI) and positron emission tomography (PET).
Cherry, Simon R. +2 more
core +1 more source
Simultaneous in vivo positron emission tomography and magnetic resonance imaging [PDF]
, 2008 Positron emission tomography (PET) and magnetic resonance imaging (MRI) are widely used in vivo imaging technologies with both clinical and biomedical research applications.
Catana, Ciprian +7 more
core +2 more sources
Analysis procedure of the positronium lifetime spectra for the J-PET detector [PDF]
, 2017 Positron Annihilation Lifetime Spectroscopy (PALS) has shown to be a powerful tool to study the nanostructures of porous materials. Positron Emissions Tomography (PET) are devices allowing imaging of metabolic processes e.g. in human bodies.
Białas, Piotr +33 more
core +2 more sources
Discordant findings of different positron emission tomography/CT tracers in a case of glioblastoma
World Journal of Nuclear Medicine, 2021 18F-2-fluoro-2-deoxy-D-glucose ([18F]-FDG) positron emission tomography (PET) CT has proven useful in the evaluation of high-grade glioma and is also useful as a predictor of the degree of malignancy in newly diagnosed brain tumors.
Ram Kumar +5 more
doaj +1 more source
Preoperative Imaging of Charcot Neuroarthropathy in Diabetic Patients: Comparison of Ring PET, Hybrid PET, and Magnetic Resonance Imaging [PDF]
, 2004 Introduction: The treatment of Charcot neuroarthropathy in the feet of diabetic patients has undergone fundamental changes in the last few years. Formerly, treatment was almost exclusively limited to nonoperative measures; since the late 1990s, however ...
Brinkbäumer, Kirsten +6 more
core +1 more source
Novel positron emission tomography radiotracers in brain tumor imaging
Indian Journal of Radiology and Imaging, 2011 Although [18F] 2-fluoro-2-deoxy-D-glucose (FDG) is the most widely used radiopharmaceutical the world over, it is not the ideal tracer for brain imaging, owing to its high physiological cortical uptake and lack of specificity.
Maria Mathew D′Souza +5 more
doaj +1 more source
Evaluation of image quality at the detector’s edge of dedicated breast positron emission tomography
EJNMMI Physics, 2021 Background Using phantoms and clinical studies in prone hanging breast imaging, we assessed the image quality of a commercially available dedicated breast PET (dbPET) at the detector’s edge, where mammary glands near the chest wall are located. These are
Yoko Satoh +4 more
doaj +1 more source
A review of PET attenuation correction methods for PET-MR
EJNMMI Physics, 2023 Despite being thirteen years since the installation of the first PET-MR system, the scanners constitute a very small proportion of the total hybrid PET systems installed.
Georgios Krokos +3 more
doaj +1 more source
Multiparametric MRI and [18F]fluorodeoxyglucose positron emission tomography imaging is a potential prognostic imaging biomarker in recurrent glioblastoma [PDF]
, 2017 Purpose/objectivesMultiparametric advanced MR and [18F]fluorodeoxyglucose (FDG)-positron emission tomography (PET) imaging may be important biomarkers for prognosis as well for distinguishing recurrent glioblastoma multiforme (GBM) from treatment-related
Akash Sharma +10 more
core +3 more sources
Deep learning for Dixon MRI-based attenuation correction in PET/MRI of head and neck cancer patients
EJNMMI Physics, 2022 Background Quantitative whole-body PET/MRI relies on accurate patient-specific MRI-based attenuation correction (AC) of PET, which is a non-trivial challenge, especially for the anatomically complex head and neck region.
Anders B. Olin +8 more
doaj +1 more source